AR001074A1 - Composición para tratar amenorrea hipotalamica en un mamifero hembra no deprimido - Google Patents

Composición para tratar amenorrea hipotalamica en un mamifero hembra no deprimido

Info

Publication number
AR001074A1
AR001074A1 AR33522696A AR33522696A AR001074A1 AR 001074 A1 AR001074 A1 AR 001074A1 AR 33522696 A AR33522696 A AR 33522696A AR 33522696 A AR33522696 A AR 33522696A AR 001074 A1 AR001074 A1 AR 001074A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
composition
female mammal
hypothalamic amenorrhea
Prior art date
Application number
AR33522696A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23502899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR001074(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR001074A1 publication Critical patent/AR001074A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición para tratar amenorrea hipotalámica en un mamífero hembra no deprimido que comprende una cantidad eficaz de un compuesto dehidrocicloalcanofenetilo de la fórmula estructural(I), en la que A es una porción de la fórmula (II), donde la línea de puntos representa insaturaciónopcional,R1 es hidrógeno o alquilo de C1-C6; R2 es alquilo de C1-C6; R4 es hidrógeno, alquilo de C1-C6, formilo o alcanoilo de C2-C7; R5 y R6 sonindependientemente hidrógeno, hidroxilo, alquilo de C1-C6, alcoxi de C1-C6, alcanoiloxi de C2-C7, ciano, nitro, alquilmercapto de C1-C6, amino, alquilaminode C1-C6, dialquilamino en que cada alquilo es de C1-C6 alcanamido de C2-C7, halo, trifluormetilo o tomados conjuntamente metilendioxi; R7 eshidrógeno oalquilo de C1-C6; n es 0, 1, 2, 3 ó 4; o una sal farmacéuticamente aceptable del mismo.
AR33522696A 1995-01-30 1996-01-29 Composición para tratar amenorrea hipotalamica en un mamifero hembra no deprimido AR001074A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/380,903 US5506270A (en) 1995-01-30 1995-01-30 Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women

Publications (1)

Publication Number Publication Date
AR001074A1 true AR001074A1 (es) 1997-09-24

Family

ID=23502899

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33522696A AR001074A1 (es) 1995-01-30 1996-01-29 Composición para tratar amenorrea hipotalamica en un mamifero hembra no deprimido

Country Status (17)

Country Link
US (1) US5506270A (es)
EP (1) EP0723779A1 (es)
JP (1) JPH08231387A (es)
KR (1) KR960028906A (es)
CN (1) CN1137894A (es)
AR (1) AR001074A1 (es)
AU (1) AU703529B2 (es)
CA (1) CA2167999A1 (es)
CZ (1) CZ22996A3 (es)
FI (1) FI956339A7 (es)
HU (1) HUT75095A (es)
IL (1) IL116935A0 (es)
NO (1) NO955356L (es)
NZ (1) NZ280744A (es)
PE (1) PE13197A1 (es)
SK (1) SK11596A3 (es)
ZA (1) ZA9511038B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
US20060068018A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
US20020022662A1 (en) * 1999-06-15 2002-02-21 American Home Products Corporation Enantiomers of O-desmethyl venlafaxine
US20020035158A1 (en) * 1999-06-15 2002-03-21 American Home Products Corporation Enantiomers of N-desmethyl venlafaxine
RU2145848C1 (ru) * 1999-07-19 2000-02-27 Авакян Гагик Норайрович Средство для лечения вторичной аменореи центрального генеза
US7291646B2 (en) * 1999-11-24 2007-11-06 Wyeth Ethers of O-desmethyl venlafaxine
US6348494B1 (en) 2000-11-21 2002-02-19 American Home Products Corporation Ethers of o-desmethyl venlafaxine
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
FR2807753B1 (fr) * 2000-04-13 2002-06-07 Adir Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2002250058B2 (en) * 2001-02-12 2007-08-16 Wyeth Llc Novel succinate salt of O-desmethyl-venlafaxine
CN1630631A (zh) * 2001-12-05 2005-06-22 惠氏公司 新的文拉法星盐酸盐多晶型物及其制备方法
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
AR039162A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Formulaciones de venlafaxina de liberacion extendida
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
EP1523981A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
WO2007005961A2 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
CA2629609A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
KR100965527B1 (ko) * 2008-05-08 2010-06-23 제일약품주식회사 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4292315A (en) * 1977-12-30 1981-09-29 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4291028A (en) * 1977-12-30 1981-09-22 Nichols Vorys Follicular phase estrogen or progestin with physiologic estrogen/progestin luteal phase replacement drug delivery system
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4826844A (en) * 1987-09-30 1989-05-02 American Home Products Corporation Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
ZA9511038B (en) 1997-06-30
CN1137894A (zh) 1996-12-18
NO955356L (no) 1996-07-31
IL116935A0 (en) 1996-05-14
US5506270A (en) 1996-04-09
NO955356D0 (no) 1995-12-29
PE13197A1 (es) 1997-04-22
NZ280744A (en) 2000-11-24
HU9503922D0 (en) 1996-03-28
FI956339L (fi) 1996-07-31
FI956339A0 (fi) 1995-12-29
AU703529B2 (en) 1999-03-25
SK11596A3 (en) 1997-05-07
CA2167999A1 (en) 1996-07-31
KR960028906A (ko) 1996-08-17
HUT75095A (en) 1997-04-28
AU4075295A (en) 1996-08-08
FI956339A7 (fi) 1996-07-31
CZ22996A3 (en) 1996-09-11
JPH08231387A (ja) 1996-09-10
EP0723779A1 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
AR001074A1 (es) Composición para tratar amenorrea hipotalamica en un mamifero hembra no deprimido
CO5011115A1 (es) Compuestos y metodos quimioquina
DK0782445T3 (da) Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
ES2164303T3 (es) Composicion acuosa de curado acelerado exenta de formaldehido para unir materiales no tejidos de fibra de vidrio resistentes al calor.
DE69434872D1 (de) Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten
ATE191521T1 (de) Fasermischung
RU98123575A (ru) Способ лечения ожирения и способ индуцирования потери веса у млекопитающих
TR200200986T2 (tr) C-aril glukozid SGLT2 önleyicileri.
ES2044087T3 (es) Un metodo para preparar una composicion de 13,14-dihidro-15-cetoprostaglandina estabilizada.
BR9914163A (pt) Agente para melhorar a potência excretora da bexiga urinária, uso de um composto de amina do tipo não carbamato que tenha uma ação inibidora de acetilcolinesterase, e, método para melhorar a potência excretora da bexiga urinária
IL134430A0 (en) Use of cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
SG165991A1 (en) Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
BR9714444A (es)
BR9813797A (pt) Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a.
HUP9802206A1 (hu) Thalidomid intravénás adagolási formája immunológiai megbetegedések gyógyításához
NZ334981A (en) Anti-convulsant derivatives such as topiramate for treating neuropathic pain
RU99107566A (ru) Производные, обладающие противосудорожным действием, пригодные для лечения невропатической боли
NO960927D0 (no) Fremgangsmåte ved fremstilling av 9-(2-hydroksy)-etoksymetylguanin
ITPD920145A1 (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
PT1019068E (pt) Formulações terapêuticas contendo veneno de serpente e/ou insecto para a profilaxia e terapia de neoplasmas
TR200001715T2 (tr) Potasyum kanalı açıcıları.
DE69529109D1 (de) Venlafaxin und seine Analoga zum Herbeiführen einer Verbesserung der kognitiven Funktionen
DK1135154T3 (da) Forbedring af follikulogenese
EA200100039A1 (ru) Способы увеличения уровней ацетилхолина
BR9807980A (pt) Uso de um composto e composto para tratar um mamìfero com disfunção cognitiva